Asuragen – QuantideX ESR1 exoMutation Kit*
ESR1 Mutations are the Leading Cause of Primary Treatment Resistance in HR+ mBC
ESR1 gene codes for estrogen receptor alpha (ERα), and mutations in its ligand-binding domain trigger constant activation of the receptor, leading to excessive downstream signalling.